A newly published review led by Gianna Wilkie and a team of researchers from the Brown University Alpert Medical School has determined cannabis inhibits tumor and reduces the severity of symptoms associated with chemotherapy treatments. The review, which can be found in JAMA Oncology, examined existing studies surrounding cannabis and its cancer-related value. The review analyzed in vivo and in vitro studies that demonstrated cannabis' ability to inhibit tumor growth through by increasing cancer cell death and suppressing cell proliferation. Both THC and CBD displayed potential antineoplastic properties. Wilkie concluded, “Cannabis in oncology may have potential in its use for anticipatory and refractory [cannabis-induced nausea and vomiting], refractory cancer pain, and as an antitumor agent.”
This information has been provided by Medical Marijuana Inc. and approved by our Chief Medical Officer.